Adding Two Medicines to Radiation for High Risk Ependymoma
Original title: Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people to check safety and find the right dose.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests two added medicines with radiation for high risk ependymoma.
Who this trial is for. This trial is for people with high risk ependymoma in the back of the brain. The tumor has not spread, and the trial adds two medicines to usual radiation.
Where it stands. The trial has not reported results. It is testing fluorouracil and tretinoin given with radiation therapy. It looks at how safe they are and what dose to use. It also looks at how well they work. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: This may be one more option for someone with this kind of tumor. A person who fits the trial could ask their care team about it.
What it doesn't mean: This does not mean these medicines work. A trial is a test, not a proven treatment. Being in one is not a promise that it will help. It is not a cure.
Source: ClinicalTrials.gov, September 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.